Esophageal Adenocarcinoma in “Mice and Men”: Back to Basics!

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Gastroenterology

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2008.02004.xPMID 18844624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma.

  2007cited by this paper
• A Novel Dietary-Related Model of Esophagitis and Barrett's Esophagus, a Premalignant Lesion

  2007cited by this paper
• Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.

  2007cited by this paper
• Models of esophageal carcinogenesis.

  2006cited by this paper
• Celecoxib for the prevention of colorectal adenomatous polyps.

  2006cited by this paper
• Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.

  2006cited by this paper
• Celecoxib for the prevention of sporadic colorectal adenomas.

  2006cited by this paper
• Translation of research evidence from animals to humans.

  2006cited by this paper
• Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.

  2006cited by this paper
• How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men.

  2005cited by this paper
• A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats

  2005cited by this paper
• Small-Bowel Metaplasia Arising in the Remnant Esophagus After Esophagogastrostomy—A Prospective Study in Patients with a History of Total Gastrectomy

  2005cited by this paper
• Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus.

  2005cited by this paper
• Small-bowel metaplasia arising in the remnant esophagus after esophagojejunostomy--a [corrected] prospective study in patients with a history of total gastrectomy.

  2005cited by this paper
• Gene expression in Barrett's esophagus and reflux esophagitis induced by gastroduodenoesophageal reflux in rats.

  2005cited by this paper
• Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species

  2005cited by this paper
• The Mutagenic Potential of Duodenoesophageal Reflux

  2005cited by this paper
• Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux.

  2005cited by this paper
• Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus

  2004cited by this paper
• Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy

  2004cited by this paper
• Impact of the Biliary Diversion Procedure on Carcinogenesis in Barrett's Esophagus Surgically Induced by Duodenoesophageal Reflux in Rats

  2004cited by this paper
• Effect of endogenous hypergastrinemia on carcinogenesis in the rat esophagus

  2004cited by this paper
• Factors Influencing The Development of Barrett's Epithelium in The Esophageal Remnant Postesophagectomy

  2004cited by this paper
• Antireflux anastomosis following oesophagectomy

  2004cited by this paper
• A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats.

  2004cited by this paper
• Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett’s metaplasia induced by duodenal contents reflux

  2003cited by this paper
• Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.

  2003cited by this paper
• Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice.

  2002cited by this paper
• A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.

  2002cited by this paper
• Metaplastic Columnar Mucosa in the Cervical Esophagus After Esophagectomy

  2002cited by this paper
• A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

  2002cited by this paper
• Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.

  2002cited by this paper
• Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.

  2002cited by this paper
• The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.

  2002cited by this paper
• Changing role of in vivo models in columnar-lined lower esophagus.

  2002cited by this paper
• Immunohistochemical study of p53, c-erbB-2, and PCNA in Barrett's esophagus with dysplasia and adenocarcinoma arising from experimental acid or alkaline reflux model

  2001cited by this paper
• Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?

  2001cited by this paper
• Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

  2000cited by this paper
• Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced?

  2000cited by this paper
• Barrett's metaplasia.

  2000cited by this paper
• An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload.

  1999cited by this paper
• Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux.

  1999cited by this paper
• An ambulant porcine model of acid reflux used to evaluate endoscopic gastroplasty

  1999cited by this paper
• Cyclooxygenase-2 expression in human esophageal carcinoma.

  1999cited by this paper
• Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

  1998cited by this paper
• Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.

  1998cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Gastric juice protects against the development of esophageal adenocarcinoma in the rat.

  1996cited by this paper
• Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade

  1996cited by this paper
• Reflux of duodenal or gastro‐duodenal contents induces esophageal carcinoma in rats

  1996cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.

  1995cited by this paper
• Effect of gastroduodenal juice and dietary fat on the development of barrett's esophagus and esophageal neoplasia: An experimental rat model

  1994cited by this paper
• Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats.

  1992cited by this paper
• The role of alkaline reflux in esophageal carcinogenesis induced by N‐amyl‐N‐methylnitrosamine in rats

  1991cited by this paper
• Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine.

  1989cited by this paper
• Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine.

  1979cited by this paper
• Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog.

  1970cited by this paper
• Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog.

  1970cited by this paper

• Esophageal adenocarcinoma models: a closer look

  2024cites this paper
• Molecular Profile of Barrett’s Esophagus and Gastroesophageal Reflux Disease in the Development of Translational Physiological and Pharmacological Studies

  2020cites this paper
• Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5−CD44+ cells

  2020cites this paper
• Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1

  2019cites this paper
• Carcinoma in situ within an area of Barrett esophagus in a dog with megaesophagus

  2018cites this paper
• A Mouse Model for Barrett’s Esophagus: Surgery and Histology

  2017cites this paper
• Barrett’s Esophagus: Pathogenesis and Prevention

  2017cites this paper
• Turning Skyscrapers into Town Houses: Insights into Barrett's Esophagus

  2016cites this paper
• Columnar Metaplasia in the Esophageal Remnant After Esophagectomy: A Common Occurrence and a Valuable Insight Into the Development of Barrett Esophagus

  2016cites this paper
• Preclinical models of esophageal adenocarcinoma for drug development.

  2016cites this paper
• Translational research on esophageal adenocarcinoma: from cell line to clinic.

  2015cites this paper
• Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1

  2015cites this paper
• Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma–Past, Present, and Future

  2015cites this paper
• Trefoil Factor Expression in a Human Model of the Early Stages of Barrett’s Esophagus

  2015cites this paper
• Strategies to identify novel therapeutic targets for oesophageal adenocarcinoma

  2014cites this paper
• Adenoviral-Based Immunotherapy Provides Local Disease Control in an Orthotopic Murine Model of Esophageal Cancer

  2014cites this paper
• Operatively induced chronic reflux in rats: a suitable model for studying esophageal carcinogenesis?

  2013cites this paper
• Exposure to gastric juice may not cause adenocarcinogenesis of the esophagus.

  2013cites this paper
• The incidence and pathogenesis of 'recurrent' Barrett's metaplasia following oesophagectomy (neo-Barrett's)

  2013cites this paper
• Cell culture models for studying the development of Barrett’s esophagus: a systematic review

  2012cites this paper
• Reply to Letter to the Editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First)

  2011cites this paper
• Berries in the Prevention of Esophageal Adenocarcinoma

  2011cites this paper
• Risk factors for neoplastic progression in Barrett's esophagus.

  2011cites this paper
• Editorial: One Small Step for Metaplasia, but One Giant Leap for Biomarkers Is Needed

  2009cites this paper
• Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo

  2009cites this paper